Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T12:50:46.761Z.
Calculation as of: 2026-10-06T12:50:46.761Z.
Quote observation: 2026-10-05T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d9f471510e2ba483dadfaa738129fdacbeb72ec081face8194c47abf0e776528
PE RATIO
N/A
Market Cap
$6.44M
PE Ratio
N/A
TTM Avg
4788.36
3Y Avg
147312.95
5Y Avg
148989.26
Market Cap
$7.03M
PE Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | $6.72M | N/A | N/A | N/A | N/A |
| Aclarion, Inc. (ACON)vs › | $6.74M | N/A | N/A | N/A | N/A |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.76M | N/A | 47.75 | 83.50 | 106.23 |
| Co-Diagnostics, Inc. (CODX)vs › | $6.88M | N/A | 4.85 | 10.48 | 10.48 |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.44M | N/A | 4788.36 | 147312.95 | 148989.26 |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.03M | N/A | N/A | N/A | N/A |
| Biomerica, Inc. (BMRA)vs › | $6.34M | N/A | 278.25 | 163.06 | 336.05 |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | N/A | N/A | N/A | N/A |
| Femasys Inc. (FEMY)vs › | $6.10M | N/A | N/A | N/A | N/A |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.10M | N/A | N/A | N/A | N/A |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$3.50
Forward EPS (Est.)
$-17.89
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
